Radiotherapy improves survival in HER2-positive breast cancer with lung metastases: a retrospective study with artificial intelligence-based prognostic modeling
RT offers a significant survival benefit in HER2-positive breast cancer patients with lung metastases. AI-based modeling enhances prognostic accuracy and supports personalized treatment decisions.
Authors
- Shanbao Ke
- Shengyuan Luo (ORCID: https://orcid.org/0000-0002-3235-6832)
- Tao Ren (ORCID: https://orcid.org/0000-0001-6641-4589)
- Xiangkun Wang (ORCID: https://orcid.org/0000-0001-7567-4702)
Institutions
- Changzhi Medical College (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Henan Provincial People's Hospital (CN)
- Heze Municipal Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3389/fonc.2025.1633448
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00